Diagnostics and therapeutics for macular degeneration-related disorders
The invention relates to methods for diagnosing and treating macular degeneration-related disorders. The invention also related to methods for identifying genes that cause macular degeneration-related disorders.
1. A method for diagnosing, or identifying a predisposition to the development of, age-related macular degeneration in a subject, comprising detecting in a biological sample from the subject the presence or abnormal levels of an autoantibody against, or an immune complex containing, at least one macular degeneration-associated molecule, wherein the macular degeneration-associated molecule is C3 convertase.
2. The method of claim 1 , wherein said biological sample is a urine, eye fluid, blood plasma, serum, whole blood, or lymph fluid from the subject.
3. The method of claim 2 , wherein said biological sample is blood plasma, serum, or whole blood from the subject.
4. The method of claim 1 , further comprising examining the subject with an ophthalmologic procedure.